DigestRedComo funciona
Red
/
Empresas
Fe
No verificado

Ferring Pharmaceuticals

Sobre qué escribimos

BiotecnologíaFarmacéuticaIndustriaMedicina - VariosSalud

34 Comunicados de prensa

Ver todos los comunicados de prensa
17/05/2026
Industria
Biotecnología
Salud
Farmacéutica
Medicina - Varios
Oncología
New Real-World Case Series Examines Re-Induction with ADSTILADRIN® (nadofaragene firadenovec-vncg) in Clinical Practice
Fuente
Ferring Pharmaceuticals
Editor
Business Wire
1.00
0
16/04/2026
Multimedia
Análisis de Mercados
Industria
Asistencia a la infancia
Política Nacional
Familia
Salud
Ir de compras
Farmacéutica
Ferring Pharmaceuticals and Gallup Announce Landmark Global Public Attitudes Study on Fertility and Family-Building
Fuente
Ferring Pharmaceuticals
Editor
Business Wire
1.00
0
24/03/2026
Industria
Biotecnología
Higiene alimentaria
Salud
Farmacéutica
Oncología
U.S. FDA Approves Label Update to Accelerate Thaw Time for ADSTILADRIN® (nadofaragene firadenovec-vncg)
Fuente
Ferring Pharmaceuticals
Editor
Business Wire
1.00
0
19/03/2026
Industria
Oncología
Salud
Medicina - Varios
Ciencia
Farmacéutica
Biotecnología
Ferring Announces Update to NCCN Guidelines Expanding Category 2A Recommendation for Nadofaragene Firadenovec-vncg (ADSTILADRIN®) in Patients with BCG-Unresponsive NMIBC
Fuente
Ferring Pharmaceuticals
Editor
Business Wire
1.00
0
10/03/2026
Ciencia
Biotecnología
Sanidad
Salud
Farmacéutica
Oncología
For the First Time, Ferring Reports Revenue of Over €2.5 Billion in 2025
Fuente
Ferring Pharmaceuticals
Editor
Business Wire
1.00
0
12/01/2026
Biotecnología
Salud
Farmacéutica
Medicina - Varios
Oncología
Mercado laboral
Industria
Ferring Pharmaceuticals and Theralase® Technologies Announce Clinical Development Agreement to Investigate Combination Therapy in Bladder Cancer
Fuente
Ferring Pharmaceuticals
Editor
Business Wire
1.00
0
02/12/2025
Ciencia
Higiene alimentaria
Biotecnología
Medicina - Varios
Salud
Farmacéutica
Oncología
Industria
SUO and Ferring Pharmaceuticals Announce the SUO Non-Muscle Invasive Bladder Cancer (NMIBC) Fellows Research Grant
Fuente
Ferring Pharmaceuticals
Editor
Business Wire
1.00
0
26/11/2025
Análisis de Mercados
Asociaciones/Profesionales
Psiquiatría
Salud
Ir de compras
Recursos Humanos
Asistencia a la infancia
Farmacéutica
With Two in Five Employees Undergoing Fertility Treatment Leaving Their Jobs or Considering Quitting, Are Companies Doing Enough?
Fuente
Ferring Pharmaceuticals
Editor
Business Wire
1.00
0
29/10/2025
Ciencia
Biotecnología
Farmacéutica
Salud
Higiene alimentaria
Medicina - Varios
Industria
Ferring Pharmaceuticals to Explore Strategic Options for Rebyota®
Fuente
Ferring Pharmaceuticals
Editor
Business Wire
1.00
0
28/10/2025
Eventos
Industria
Ciencia
Higiene alimentaria
Biotecnología
Medicina - Varios
Farmacéutica
Salud
Oncología
Ferring Highlights New Real-World Research with ADSTILADRIN® (nadofaragene firadenovec-vncg) in Clinical Practice
Fuente
Ferring Pharmaceuticals
Editor
Business Wire
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0